US stroke legislation is revised after BMJ airs controversyBMJ 2004; 328 doi: https://doi.org/10.1136/bmj.328.7440.604-f (Published 11 March 2004) Cite this as: BMJ 2004;328:604
- Jeanne Lenzer
- New York
Controversial federal legislation that would have designated hospitals as “stroke centres” only if they were prepared to administer alteplase for acute stroke has been radically altered.
A revised version of the Stroke Treatment and Ongoing Prevention Act, sponsored by Congresswoman Lois Capps, passed the US House Energy and Commerce Committee and will move to the full House of Representatives for a vote.
Provisions in the legislation that focused on getting patients to designated hospitals for treatment with alteplase were deleted. Funding for the entire five year programme was cut from approximately $665m (£360m; €540m) to $95m. Up to seven grants totalling $50m …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial